Grace R. Jeschke

1.6k citations

28 papers · 841 indexed · h-index 13

Co-authors: Benjamin E. Turk Cristina I. Caescu Alexander E. Perl Catherine C. Smith Neil P. Shah Kimberly C. Lin Martin Carroll Jeremy Thorner
Topics: Acute Myeloid Leukemia Research (10 papers)Chronic Myeloid Leukemia Treatments (7 papers)Chronic Lymphocytic Leukemia Research (5 papers)
Cited by: Hematology Genetics Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Genes & Development
Partner nations: United States Australia Denmark

In The Last Decade

Grace R. Jeschke

27 papers receiving 837 citations

Peers

Countries citing papers authored by Grace R. Jeschke

Since Specialization

Citations

This map shows the geographic impact of Grace R. Jeschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace R. Jeschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace R. Jeschke more than expected).

Fields of papers citing papers by Grace R. Jeschke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace R. Jeschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace R. Jeschke. The network helps show where Grace R. Jeschke may publish in the future.

Co-authorship network of co-authors of Grace R. Jeschke

This figure shows the co-authorship network connecting the top 25 collaborators of Grace R. Jeschke. A scholar is included among the top collaborators of Grace R. Jeschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace R. Jeschke. Grace R. Jeschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia 2023 ·Cancers ·Neil Palmisiano,Grace R. Jeschke,Lindsay Wilde,Önder Alpdoğan,Matthew Carabasi,Joanne Filicko-O’Hara,Dolores Grosso,Thomas R. Klumpp,(unknown),John L. Wagner,Martin Carroll,Alexander E. Perl,Margaret Kasner	0
2	LepTraits 1.0 A globally comprehensive dataset of butterfly traits 2022 ·Scientific Data ·Vaughn Shirey,Elise A. Larsen,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Michael W. Belitz,Grace R. Jeschke,Vijay Barve,Gerardo Lamas,Akito Y. Kawahara,Robert Guralnick,Naomi E. Pierce,David J. Lohman,Leslie Ries	35
3	Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer 2022 ·npj Breast Cancer ·Igor Makhlin,Nicholas P. McAndrew,E. Paul Wileyto,Amy S. Clark,Robin Holmes,(unknown),Clementina Mesaros,Ian A. Blair,Grace R. Jeschke,Kevin R. Fox,Susan M. Domchek,Jennifer M. Matro,Angela R. Bradbury,Michael D. Feldman,Elizabeth O. Hexner,Jacqueline Bromberg,Angela DeMichele	5
4	Global view of the RAF-MEK-ERK module and its immediate downstream effectors 2019 ·Scientific Reports ·(unknown),James Longden,Erwin M. Schoof,Craig D. Simpson,Grace R. Jeschke,Pau Creixell,Jin-Ho Kim,Xuewei Wu,Benjamin E. Turk,Neal Rosen,Poulikos I. Poulikakos,Rune Linding	8
5	Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition 2018 ·Investigational New Drugs ·Margaret Kasner,Rosemarie Mick,Grace R. Jeschke,Matthew Carabasi,Joanne Filicko-O’Hara,Neal Flomenberg,Noelle V. Frey,Elizabeth O. Hexner,Selina M. Luger,Alison W. Loren,James K. Mangan,John L. Wagner,Mark A. Weiss,Martin Carroll,Alexander E. Perl	17
6	Substrate priming enhances phosphorylation by the budding yeast kinases Kin1 and Kin2 2018 ·Journal of Biological Chemistry ·Grace R. Jeschke,Hua Jane Lou,(unknown),Charlotte I. Hammond,(unknown),Patrick Brennwald,Benjamin E. Turk	4
7	Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis 2017 ·Blood ·Catherine C. Smith,Amy L. Paguirigan,Grace R. Jeschke,Kimberly C. Lin,Evan Massi,(unknown),Chen-Shan Chin,Saurabh Asthana,Adam B. Olshen,Kevin Travers,Susana Wang,Mark J. Levis,Alexander E. Perl,Jerald P. Radich,Neil P. Shah	120
8	Differentiation Response to Quizartinib, a Potent 2nd Generation FLT3 Inhibitor, in Relapsed FLT3 -Mutant AML Patients Correlates with Specific DNA Methylation Signature Prior to Therapy 2017 ·Blood ·Miguel Torres‐Martín,Grace R. Jeschke,Alexander E. Perl,Martin Carroll,María E. Figueroa	1
9	A Phase II Study of Azacitidine and Sirolimus for the Treatment of Acute Myeloid Leukemia (AML) Refractory to or Not Eligible for Intensive Chemotherapy or High Risk Myelodysplastic Syndrome (MDS) 2017 ·Blood ·Neil Palmisiano,Grace R. Jeschke,Lindsay Wilde,Benjamin E. Leiby,Önder Alpdoğan,(unknown),Joanne Filicko-O’Hara,Sameh Gaballa,Dolores Grosso,Thomas R. Klumpp,(unknown),John L. Wagner,Martin Carroll,Pierluigi Porcu,Neal Flomenberg,Alexander E. Perl,Margaret Kasner	1
10	CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies 2017 ·Genes & Development ·Kaosheng Lv,Jing Jiang,(unknown),(unknown),Ying Cheng,Vemika Chandra,(unknown),Wei An,Bhopal Mohapatra,Benjamin T. Goetz,Vinodh Pillai,(unknown),(unknown),Grace R. Jeschke,Wallace Y. Langdon,Suresh Kumar,Elizabeth O. Hexner,Hamid Band,Wei Tong	46
11	AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding protein 2015 ·Mechanisms of Development ·(unknown),Alyssa A. Lombardi,Grace R. Jeschke,Elizabeth O. Hexner,Janice Russell	6
12	Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3 2014 ·Proceedings of the National Academy of Sciences ·Jacob A. Galán,(unknown),Geneviève Lavoie,Evgeny Kanshin,Joseph Tcherkezian,(unknown),Grace R. Jeschke,Benjamin E. Turk,Bryan A. Ballif,John Blenis,Pierre Thibault,Philippe P. Roux	61
13	Intrinsic Resistance to JAK2 Inhibition in Myelofibrosis 2013 ·Clinical Cancer Research ·Anna Kalota,Grace R. Jeschke,Martin Carroll,Elizabeth O. Hexner	13
14	Lineage- and Developmental Stage-Specific Patterns Of Auf-1 Isoform Expression Contribute To The Regulation Of Erythroid-Specific mRNAs 2013 ·Blood ·(unknown),Grace R. Jeschke,Elizabeth O. Hexner,Janice Russell	1
15	Cyclic GMP-dependent Stimulation of Serotonin Transport Does Not Involve Direct Transporter Phosphorylation by cGMP-dependent Protein Kinase 2012 ·Journal of Biological Chemistry ·Albert Wong,Yuan‐Wei Zhang,Grace R. Jeschke,Benjamin E. Turk,Gary Rudnick	15
16	Reciprocal Phosphorylation of Yeast Glycerol-3-Phosphate Dehydrogenases in Adaptation to Distinct Types of Stress 2012 ·Molecular and Cellular Biology ·(unknown),Grace R. Jeschke,Françoise M. Roelants,Jeremy Thorner,Benjamin E. Turk	92
17	Defining the Substrate Specificity Determinants Recognized by the Active Site of C-Terminal Src Kinase-Homologous Kinase (CHK) and Identification of β-Synuclein as a Potential CHK Physiological Substrate 2011 ·Biochemistry ·(unknown),Grace R. Jeschke,Yang Deng,(unknown),Nicholas A. Williamson,Denis B. Scanlon,Janetta G. Culvenor,Mohammed Iqbal Hossain,Anthony W. Purcell,Sheng Liu,Hong‐Jian Zhu,Bruno Catimel,Benjamin E. Turk,Heung‐Chin Cheng	10
18	Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein in AML Blasts During Trials Combining Sirolimus and Intensive Chemotherapy: Target Inhibition Enhances Response 2011 ·Blood ·Margaret Kasner,Selina M. Luger,Grace R. Jeschke,Rosemarie Mick,Martin Carroll,Alexander E. Perl	2
19	Intrinsic Resistance to JAK2 Inhibition in Myelofibrosis 2011 ·Blood ·Anna Kalota,Grace R. Jeschke,Martin Carroll,Elizabeth O. Hexner	1
20	Phospho-Specific Flow Cytometry of Fixed Whole Blood Demonstrates In Vivo FLT3 Inhibition in Circulating Leukemic Blasts During AC220 Therapy and Accurately Detects the Development of Therapeutic Resistance, 2011 ·Blood ·Alexander E. Perl,Grace R. Jeschke,Catherine C. Smith,James K. Mangan,Selina M. Luger,Martin Carroll	2

About Grace R. Jeschke

Grace R. Jeschke is a scholar working on Hematology, Genetics and Ecological Modeling, having authored 28 papers that have together received 841 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Hematology (343 citations), Genetics (156 citations) and Molecular Biology (488 citations). Grace R. Jeschke has collaborated with scholars based in United States, Australia and Denmark. Frequent co-authors include Benjamin E. Turk, Cristina I. Caescu, Alexander E. Perl, Catherine C. Smith, Neil P. Shah, Kimberly C. Lin, Martin Carroll, Jeremy Thorner, Françoise M. Roelants and Lauren E. Damon. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact